Physician profile
Matthew Christopher Nickolas
NPI 1942641709
$5,460.25
in general payments reported to CMS, 2019-2025
12 companies · $150 in 2025
The $150 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,694 · 2021: $1,450 · 2022: $381 · 2023: $1,700 · 2024: $85.15 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,454 · Food and Beverage: $412 · Gift: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,453.61 |
| Food and Beverage | $411.75 |
| Gift | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,196.08 | 2022-2025 | |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Dentsply Sirona INC | $665.00 | 2019-2021 | |
| Patterson Companies, INC. | $602.50 | 2021 | |
| Straumann USA LLC | $247.89 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $103.27 | 2019-2021 | |
| A-Dec, INC. | $70.00 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $19.07 | 2025 | Arestin, Ossix Plus |
| Envista Holdings Corporation | $18.73 | 2025 | Nexus Rmgi |
| 3m Company | $17.51 | 2021 | |
| Biolase, INC. | $12.67 | 2022 | |
| Voco America INC. | $7.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nickolas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.